Sirolimus-eluting or everolimus-eluting stents for coronary artery disease: 5-year outcomes of the randomised BIOFLOW-IV trial

Affiliations

• ¹ Cardiology Unit, OLVG, Amsterdam, the Netherlands.
• ² Herzzentrum, Segeberger Kliniken, Bad Segeberg, Germany.
• ³ Department of Cardiology and Pneumology, Helios Amper-Klinikum, Dachau, Germany.
• ⁴ Lukaskrankenhaus Medizinische Klinik I, Städtische Kliniken Neuss, Neuss, Germany.
• ⁵ Department of Cardiology, Hospital Clínic de Barcelona, Barcelona, Spain.
• ⁶ Haemodynamic Unit, Hospital Universitario Virgen Macarena, Seville, Spain.
• ⁷ National Institute of Cardiology, Warsaw, Poland.
• ⁸ Kansai Rosai Hospital Cardiovascular Center, Amagasaki, Japan.
• ⁹ Sakurakai Takahashi Hospital, Kobe, Japan.
• ¹⁰ MedStar Health Research Institute, Washington, DC, USA.
• ¹¹ Okinawa Tokushukai Shonan Kamakura General Hospital, Kamakura, Japan.